Fan Yongqiang, Liu Min, Liu Anquan, Cui Nailing, Chen Zhimei, Yang Qian, Su Aihua
Department of Gastroenterology, Sunshine Union Hospital, Weifang City, Shandong Province, People's Republic of China.
Department of Gastroenterology, Weifang Medical University, Weifang City, Shandong Province, People's Republic of China.
Cancer Manag Res. 2021 May 11;13:3789-3801. doi: 10.2147/CMAR.S290629. eCollection 2021.
Gastric cancer (GC) is a common and deadly malignancy in the world. CircRNAs have emerged as important regulators in human diseases, including GC. In this work, we intended to explore the role of circ_CORO1C in GC progression and potential mechanism.
Quantitative real-time PCR (qRT-PCR) or Western blot assay was performed to examine the expression of circRNA coronin-like actin-binding protein 1C (circ_CORO1C), microRNA (miR)-138-5p and Krueppel-like factor 12 (KLF12) in clinical samples and cells. Cell colony formation ability and viability were measured by colony formation assay and methyl thiazolyl tetrazolium (MTT) assay, respectively. Expression of cell proliferation and epithelia-mesenchymal transition (EMT) biomarker was detected by Western blot analysis. And cell metastasis, including migration and invasion, and apoptosis were analyzed via Transwell assay and flow cytometry, respectively. Target relationship among circ_CORO1C, miR-138-5p and KLF12 was validated by dual-luciferase reporter assay. The in vivo role of circ_CORO1C was investigated by tumor xenograft assay.
Circ_CORO1C and KLF12 were upregulated, while miR-138-5p was downregulated in GC tissues and cells. Circ_CORO1C knockdown suppressed colony formation ability, viability, migration, invasion and EMT in GC cells, while promoted cell apoptosis in vitro. Circ_CORO1C targeted miR-138-5p, the inhibition of which could attenuate silenced circ_CORO1C-induced inhibitory effects on GC progression. MiR-138-5p repressed the aggressive malignant behaviors of GC cells by directly targeting KLF12. Circ_CORO1C deficiency inhibited GC tumor growth in vivo.
Depletion of circ_CORO1C suppressed GC progression by regulating miR-138-5p/KLF12 axis, offering a potential molecular target for GC therapy.
胃癌(GC)是全球常见的致命性恶性肿瘤。环状RNA(circRNAs)已成为包括胃癌在内的人类疾病中的重要调节因子。在本研究中,我们旨在探讨环状冠蛋白样肌动蛋白结合蛋白1C(circ_CORO1C)在胃癌进展中的作用及其潜在机制。
采用定量实时聚合酶链反应(qRT-PCR)或蛋白质免疫印迹法检测临床样本和细胞中circRNA冠蛋白样肌动蛋白结合蛋白1C(circ_CORO1C)、微小RNA(miR)-138-5p和克鲁ppel样因子12(KLF12)的表达。分别通过集落形成试验和甲基噻唑基四氮唑(MTT)试验检测细胞集落形成能力和活力。通过蛋白质免疫印迹分析检测细胞增殖和上皮-间质转化(EMT)生物标志物的表达。分别通过Transwell试验和流式细胞术分析细胞迁移、侵袭等转移情况以及细胞凋亡情况。通过双荧光素酶报告基因试验验证circ_CORO1C、miR-138-5p和KLF12之间的靶向关系。通过肿瘤异种移植试验研究circ_CORO1C在体内的作用。
在胃癌组织和细胞中,circ_CORO1C和KLF12表达上调,而miR-138-5p表达下调。敲低circ_CORO1C可抑制胃癌细胞的集落形成能力、活力、迁移、侵袭和EMT,同时促进体外细胞凋亡。circ_CORO1C靶向miR-138-5p,抑制miR-138-5p可减弱circ_CORO1C沉默诱导的对胃癌进展的抑制作用。miR-138-5p通过直接靶向KLF12抑制胃癌细胞的侵袭性恶性行为。circ_CORO1C缺失在体内抑制胃癌肿瘤生长。
circ_CORO1C的缺失通过调节miR-138-5p/KLF12轴抑制胃癌进展,为胃癌治疗提供了一个潜在的分子靶点。